Compare $PBYI vs $RGNX | Chartloom

Compare

$PBYI vs $RGNX

Puma Biotechnology Inc · Regenxbio Inc

PBYI

Puma Biotechnology Inc

RGNX

Regenxbio Inc

Compare $PBYI vs $RGNX

Comparing Puma Biotechnology Inc and Regenxbio Inc

PBYIPuma Biotechnology Inc

RGNXRegenxbio Inc

PBYIPuma Biotechnology Inc

Market cap

$524M

P/E (TTM)

20.26x

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-2.9%

YTD performance

78.3%

52W performance

96.7%

FCF yield

7.8%

RGNXRegenxbio Inc

Market cap

$511M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

5.95x

Rev growth (TTM)

12.0%

YTD performance

-40.5%

52W performance

-34.0%

FCF yield

-48.9%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

PBYI

RGNX

Detailed metrics comparison

PBYI

Puma Biotechnology Inc

RGNX

Regenxbio Inc

Market Cap

PBYI$524M

RGNX$511M

Enterprise Value

PBYI$487M

RGNX$656M

Price

PBYI$10.29

RGNX$8.07

P/E Ratio

PBYI20.26x

RGNXN/A

P/S Ratio

PBYI2.26x

RGNX2.93x

EV/Sales

PBYI2.11x

RGNX3.76x

EV/EBITDA

PBYI10.51x

RGNX5.30x

P/B Ratio

PBYI3.54x

RGNX6.83x

P/FCF Ratio

PBYI12.75x

RGNXN/A

EV/FCF

PBYI11.86x

RGNX-2.63x

PEG Ratio

PBYIN/A

RGNXN/A

Forward P/E (NTM)

PBYIN/A

RGNXN/A

Forward P/S (NTM)

PBYIN/A

RGNX5.95x

Revenue (TTM)

PBYI$231M

RGNX$174M

Revenue Growth (YoY)

PBYI-2.9%

RGNX12.0%

Forward Rev Growth

PBYI-1.4%

RGNX25.9%

Gross Margin (TTM)

PBYI74.8%

RGNX86.4%

Operating Margin (TTM)

PBYI13.2%

RGNX0.0%

EBITDA Margin (TTM)

PBYI17.7%

RGNX-85.3%

Net Margin (TTM)

PBYI11.6%

RGNX-112.6%

FCF Margin (TTM)

PBYI17.8%

RGNX-143.1%

Net Income (TTM)

PBYI$27M

RGNX$-196M

FCF (TTM)

PBYI$41M

RGNX$-250M

EPS (TTM)

PBYI$0.51

RGNX-$3.71

ROE (TTM)

PBYI20.8%

RGNX-22007.0%

ROA (TTM)

PBYI13.3%

RGNX-4604.0%

ROIC (TTM)

PBYI18.4%

RGNX-7179.0%

Cash

PBYI$37M

RGNX$36M

Debt

PBYI$0

RGNX$182M

Net Cash/Debt

PBYI$37M

RGNX$-145M

Current Ratio (TTM)

PBYI2.91x

RGNX2.86x

Quick Ratio (TTM)

PBYI2.57x

RGNX2.71x

Debt/Equity (TTM)

PBYI0.17x

RGNX2.53x

Debt/Assets (TTM)

PBYI0.0%

RGNX0.0%

Interest Coverage (TTM)

PBYIN/A

RGNXN/A

Net Debt/EBITDA (TTM)

PBYI0.00x

RGNX0.00x

Beta

PBYI1.36

RGNX1.21

52W Performance

PBYI96.7%

RGNX-34.0%

YTD Performance

PBYI78.3%

RGNX-40.5%

% from 52W High

PBYI-0.8%

RGNX-50.2%

% from 52W Low

PBYI124.7%

RGNX47.9%

Asset Turnover (TTM)

PBYI1.15x

RGNX0.41x

FCF Yield (TTM)

PBYI7.8%

RGNX-48.9%

Earnings Yield (TTM)

PBYI5.1%

RGNX-38.5%

Dividend Yield (TTM)

PBYIN/A

RGNXN/A

Rule of 40

PBYI14.9

RGNX-131.1

EV/GP/RG

PBYIN/A

RGNX0.15

Ticker research

View PBYI research View RGNX research

Metric	PBYI Puma Biotechnology Inc	RGNX Regenxbio Inc
Market & Valuation
Market Cap	$524M	$511M
Enterprise Value	$487M	$656M
Price	$10.29	$8.07
P/E Ratio	20.26x	N/A
P/S Ratio	2.26x	2.93x
EV/Sales	2.11x	3.76x
EV/EBITDA	10.51x	5.30x
P/B Ratio	3.54x	6.83x
P/FCF Ratio	12.75x	N/A
EV/FCF	11.86x	-2.63x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	5.95x
Revenue & Growth
Revenue (TTM)	$231M	$174M
Revenue Growth (YoY)	-2.9%	12.0%
Forward Rev Growth	-1.4%	25.9%
Profitability
Gross Margin (TTM)	74.8%	86.4%
Operating Margin (TTM)	13.2%	0.0%
EBITDA Margin (TTM)	17.7%	-85.3%
Net Margin (TTM)	11.6%	-112.6%
FCF Margin (TTM)	17.8%	-143.1%
Net Income (TTM)	$27M	$-196M
FCF (TTM)	$41M	$-250M
EPS (TTM)	$0.51	-$3.71
ROE (TTM)	20.8%	-22007.0%
ROA (TTM)	13.3%	-4604.0%
ROIC (TTM)	18.4%	-7179.0%
Financial Health
Cash	$37M	$36M
Debt	$0	$182M
Net Cash/Debt	$37M	$-145M
Current Ratio (TTM)	2.91x	2.86x
Quick Ratio (TTM)	2.57x	2.71x
Debt/Equity (TTM)	0.17x	2.53x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.36	1.21
52W Performance	96.7%	-34.0%
YTD Performance	78.3%	-40.5%
% from 52W High	-0.8%	-50.2%
% from 52W Low	124.7%	47.9%
Efficiency & Yields
Asset Turnover (TTM)	1.15x	0.41x
FCF Yield (TTM)	7.8%	-48.9%
Earnings Yield (TTM)	5.1%	-38.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	14.9	-131.1
EV/GP/RG	N/A	0.15
Ticker research	View PBYI research	View RGNX research

Valuation

P/E Ratio

PBYI

20.26x

P/S Ratio

PBYI

2.26x

RGNX

2.93x

EV/FCF

RGNX

-2.63x

PBYI

11.86x

Growth & revenue

Revenue Growth TTM

RGNX

12.0%

PBYI

-2.9%

Forward Revenue Growth

RGNX

25.9%

PBYI

-1.4%

Profitability & performance

Gross Margin

RGNX

86.4%

PBYI

74.8%

ROE

PBYI

20.8%

RGNX

-22007.0%

FCF Yield %

PBYI

7.8%

RGNX

-48.9%

52-Week Performance

PBYI

96.7%

RGNX

-34.0%

Detailed metrics comparison

PBYI

Puma Biotechnology Inc

RGNX

Regenxbio Inc

Market Cap

PBYI$524M

RGNX$511M

Enterprise Value

PBYI$487M

RGNX$656M

Price

PBYI$10.29

RGNX$8.07

P/E Ratio

PBYI20.26x

RGNXN/A

P/S Ratio

PBYI2.26x

RGNX2.93x

EV/Sales

PBYI2.11x

RGNX3.76x

EV/EBITDA

PBYI10.51x

RGNX5.30x

P/B Ratio

PBYI3.54x

RGNX6.83x

P/FCF Ratio

PBYI12.75x

RGNXN/A

EV/FCF

PBYI11.86x

RGNX-2.63x

PEG Ratio

PBYIN/A

RGNXN/A

Forward P/E (NTM)

PBYIN/A

RGNXN/A

Forward P/S (NTM)

PBYIN/A

RGNX5.95x

Revenue (TTM)

PBYI$231M

RGNX$174M

Revenue Growth (YoY)

PBYI-2.9%

RGNX12.0%

Forward Rev Growth

PBYI-1.4%

RGNX25.9%

Gross Margin (TTM)

PBYI74.8%

RGNX86.4%

Operating Margin (TTM)

PBYI13.2%

RGNX0.0%

EBITDA Margin (TTM)

PBYI17.7%

RGNX-85.3%

Net Margin (TTM)

PBYI11.6%

RGNX-112.6%

FCF Margin (TTM)

PBYI17.8%

RGNX-143.1%

Net Income (TTM)

PBYI$27M

RGNX$-196M

FCF (TTM)

PBYI$41M

RGNX$-250M

EPS (TTM)

PBYI$0.51

RGNX-$3.71

ROE (TTM)

PBYI20.8%

RGNX-22007.0%

ROA (TTM)

PBYI13.3%

RGNX-4604.0%

ROIC (TTM)

PBYI18.4%

RGNX-7179.0%

Cash

PBYI$37M

RGNX$36M

Debt

PBYI$0

RGNX$182M

Net Cash/Debt

PBYI$37M

RGNX$-145M

Current Ratio (TTM)

PBYI2.91x

RGNX2.86x

Quick Ratio (TTM)

PBYI2.57x

RGNX2.71x

Debt/Equity (TTM)

PBYI0.17x

RGNX2.53x

Debt/Assets (TTM)

PBYI0.0%

RGNX0.0%

Interest Coverage (TTM)

PBYIN/A

RGNXN/A

Net Debt/EBITDA (TTM)

PBYI0.00x

RGNX0.00x

Beta

PBYI1.36

RGNX1.21

52W Performance

PBYI96.7%

RGNX-34.0%

YTD Performance

PBYI78.3%

RGNX-40.5%

% from 52W High

PBYI-0.8%

RGNX-50.2%

% from 52W Low

PBYI124.7%

RGNX47.9%

Asset Turnover (TTM)

PBYI1.15x

RGNX0.41x

FCF Yield (TTM)

PBYI7.8%

RGNX-48.9%

Earnings Yield (TTM)

PBYI5.1%

RGNX-38.5%

Dividend Yield (TTM)

PBYIN/A

RGNXN/A

Rule of 40

PBYI14.9

RGNX-131.1

EV/GP/RG

PBYIN/A

RGNX0.15

Ticker research

View PBYI research View RGNX research

Metric	PBYI Puma Biotechnology Inc	RGNX Regenxbio Inc
Market & Valuation
Market Cap	$524M	$511M
Enterprise Value	$487M	$656M
Price	$10.29	$8.07
P/E Ratio	20.26x	N/A
P/S Ratio	2.26x	2.93x
EV/Sales	2.11x	3.76x
EV/EBITDA	10.51x	5.30x
P/B Ratio	3.54x	6.83x
P/FCF Ratio	12.75x	N/A
EV/FCF	11.86x	-2.63x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	5.95x
Revenue & Growth
Revenue (TTM)	$231M	$174M
Revenue Growth (YoY)	-2.9%	12.0%
Forward Rev Growth	-1.4%	25.9%
Profitability
Gross Margin (TTM)	74.8%	86.4%
Operating Margin (TTM)	13.2%	0.0%
EBITDA Margin (TTM)	17.7%	-85.3%
Net Margin (TTM)	11.6%	-112.6%
FCF Margin (TTM)	17.8%	-143.1%
Net Income (TTM)	$27M	$-196M
FCF (TTM)	$41M	$-250M
EPS (TTM)	$0.51	-$3.71
ROE (TTM)	20.8%	-22007.0%
ROA (TTM)	13.3%	-4604.0%
ROIC (TTM)	18.4%	-7179.0%
Financial Health
Cash	$37M	$36M
Debt	$0	$182M
Net Cash/Debt	$37M	$-145M
Current Ratio (TTM)	2.91x	2.86x
Quick Ratio (TTM)	2.57x	2.71x
Debt/Equity (TTM)	0.17x	2.53x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.36	1.21
52W Performance	96.7%	-34.0%
YTD Performance	78.3%	-40.5%
% from 52W High	-0.8%	-50.2%
% from 52W Low	124.7%	47.9%
Efficiency & Yields
Asset Turnover (TTM)	1.15x	0.41x
FCF Yield (TTM)	7.8%	-48.9%
Earnings Yield (TTM)	5.1%	-38.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	14.9	-131.1
EV/GP/RG	N/A	0.15
Ticker research	View PBYI research	View RGNX research